Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

Información del proyecto

NANOBIO4CAN

Identificador del acuerdo de subvención: 101126492

DOI

10.3030/101126492

Fecha de la firma de la CE 18 Septiembre 2023

Fecha de inicio 1 Noviembre 2023

Fecha de finalización 31 Octubre 2028

Financiado con arreglo a

• Marie Skłodowska-Curie Actions (MSCA)

Coste total

Sin datos

Aportación de la UE

€ 2 292 480,00

Coordinado por

SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM
Türkiye

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Other (2)

Call 2 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Call 1 – Link to Euraxess website

Inform the Project Officer on publishing each call for proposals, by sending the link to the Euraxess website and a screen shot of the related call announcement.

Documents, reports (1)

Call 1 – Report on dissemination activities

Dates/Interval of call publication and dissemination channels/means (supporting documents are required as images, screen shots, photos from events).Flyers, brochures, or other information produced for dissemination of the callPresentations held at conferences and/or meetings and/or other eventsArticles published in the press (please list and attach only main articles)Any other means for advertising the programme

Publicaciones

Conference proceedings (9)

DISSECTING TUMOR IMMUNE MICROENVIRONMENT IN HOSPITALIZED LUNG CANCER PATIENTS

Autores: Saif Ullah Afridi, Devrim Gözüaçık, Abdullah Karadağ
Editor: Gebze Technical University
DOI: 10.5281/ZENODO.20818489

Hyaluronic acid-functionalized CaCO₃ crystals as novel polyelectrolytemultilayer reservoirs for CPT-RB (Chemotherapy and Photodynamictherapy) targeting multiple myeloma

Autores: Nemany Hanafy, Safacan Kölemen
Editor: MDPI, The publisher of the Sciforum.net Platform
DOI: 10.5281/ZENODO.20818713

Synthesis and Engineering of Redox-Active NanoMOFs For PDT: A Step Towards Light-Triggered Cancer Therapeutics

Autores: Ankush Sontakke, Funda Acar Yağcı
Editor: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817678

Photodynamic therapy combined with chemotherapy represents a novel strategy in multiple myeloma treatment: Nano-Multilayered strategy

Autores: A.N. Hanafy, Nemany, Kolemen, Safacan
Editor: Acıbadem Mehmet Ali Aydınlar University, In the framework of the International Day of Light 2026
DOI: 10.5281/ZENODO.21929621

Strain Development of Pichia Pastoris with Knockout of Calcium and Manganese Transporting ATPase (GDT1 and PMR1) Gene Through CRISPR-Cas9 Editing

Autores: Noor Hamizah Binti Suhaimi, Mehmet İnan
Editor: Zenodo
DOI: 10.5281/ZENODO.20818812

Functionalization of CaCO₃ crystals as novel polyelectrolyte multilayer reservoir for drug delivery

Autores: Nemany Hanafy, Safacan Kölemen
Editor: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818077

REASSESSING THE ROLE OF ANTIGEN PROCESSING MACHINERY IN NEXTGENERATION PRECISION MEDICINE

Autores: Ika Nurlaila,Abdullah Karadağ
Editor: Gebze Technical University
DOI: 10.5281/ZENODO.20818120

Optimization of Soysaponin-Carbon Quantum Dots as Naturally Derived and Cost-Effective Theranostic CQDs for Targeted Imaging of Cancer Cells

Autores: Nemany Hanafy, Safacan Kölemen
Editor: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20818048

PB41 İN VİVO AKCİĞER TÜMÖR MİKROÇEVRESİNİ İNCELEMEK İÇİN TEKRARLANABİLİR YÖNTEM: ASPİRASYONLA OLUŞTURULAN ORTOTOPİK AKCİĞER KANSER MODELİ

Autores: Müge Özkan, Bilgi Güngör
Editor: XXVII. Ulusal İmmünoloji Kongresi
DOI: 10.5281/ZENODO.20818580

Other (1)

Molecular markers: BCL10

Autores: AFRIDI, SAIFULLAH, Karadag, Abdullah
Editor: PathologyOutlines.com
DOI: 10.5281/ZENODO.21470252

Peer reviewed articles (4)

Antibacterial Efficacy of Ti3C2Tx and Nb2CTx MXenes Against Gram-Positive and Gram-Negative Bacterial Strains

Autores: Mina Masoudi, Mina Namvari
Editor: NanoTR: Nanoscience and Nanotechnology Community
DOI: 10.5281/ZENODO.20817968

RSC Advances

Autores: Nemany A. N. Hanafy, Safacan Kolemen
Publicado en: RSC Advances, Edición 16, 2026, ISSN 2046-2069
Editor: Royal Society of Chemistry
DOI: 10.1039/D5RA09823H

Spectral characterization and development of UV, direct fluorescence, and RP-HPLC-FLD assays for quantifying the BUB1 inhibitor BAY-1816032 in serum to support preclinical development

Autores: Fazel Gorjipour, Serif Senturk
Publicado en: Results in Chemistry, Edición 29, 2026, ISSN 2211-7156
Editor: Elsevier BV
DOI: 10.1016/J.RECHEM.2026.103693

Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects

Autores: Kashif Maroof, Ronald Fook Seng Lee, Pinar Karacabey, Rükan Genç
Publicado en: ACS Pharmacology & Translational Science, Edición 9, 2026, ISSN 2575-9108
Editor: American Chemical Society (ACS)
DOI: 10.1021/ACSPTSCI.5C00719